IRIS
BUCOLO, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.310
EU - Europa 4.683
AS - Asia 2.896
SA - Sud America 568
AF - Africa 462
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.988
IT - Italia 1.795
SG - Singapore 1.678
IE - Irlanda 1.052
CN - Cina 980
UA - Ucraina 867
BR - Brasile 527
CA - Canada 297
CI - Costa d'Avorio 272
RU - Federazione Russa 258
DE - Germania 231
SN - Senegal 142
SE - Svezia 113
GB - Regno Unito 66
IN - India 60
FI - Finlandia 49
FR - Francia 45
CH - Svizzera 43
VN - Vietnam 33
NL - Olanda 30
BE - Belgio 27
UZ - Uzbekistan 23
GR - Grecia 18
NG - Nigeria 18
PL - Polonia 18
ES - Italia 17
AT - Austria 16
HK - Hong Kong 15
MX - Messico 14
TR - Turchia 13
BD - Bangladesh 12
IQ - Iraq 12
JP - Giappone 11
AR - Argentina 10
LB - Libano 10
MA - Marocco 10
AU - Australia 9
EU - Europa 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
ZA - Sudafrica 8
CO - Colombia 7
HR - Croazia 6
IR - Iran 6
HN - Honduras 5
IL - Israele 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
ID - Indonesia 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 16.939
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.497
Chandler 1.179
Dublin 1.045
Singapore 919
Jacksonville 884
Catania 556
Chicago 524
Boardman 452
Nanjing 291
Lawrence 283
Cambridge 277
Andover 274
Abidjan 272
Houston 243
Toronto 231
Ashburn 221
Des Moines 144
Dakar 142
San Mateo 129
Wilmington 120
Civitanova Marche 102
Grafing 85
Nanchang 79
Shenyang 69
Florence 67
Saint Petersburg 67
Hebei 65
Ottawa 65
Council Bluffs 56
Jiaxing 56
Rome 56
Bremen 55
Tianjin 48
Changsha 47
Palermo 45
Messina 41
São Paulo 36
Los Angeles 33
Redwood City 32
Milan 28
Moscow 28
Dong Ket 27
Falls Church 27
Aci Catena 26
Seattle 26
Dearborn 25
Helsinki 25
Beijing 22
Hangzhou 22
Pune 22
Brussels 21
Naples 21
Washington 21
Belo Horizonte 20
Ningbo 20
Norwalk 20
Pozzallo 20
Lappeenranta 19
Munich 19
Abuja 18
Jinan 18
Liberty Lake 18
Zhengzhou 18
Guangzhou 17
Rio de Janeiro 17
Lissone 15
Shanghai 15
Den Haag 14
The Dalles 14
Padova 13
Brasília 12
Curitiba 12
Redmond 12
Paternò 11
Reggio Calabria 11
Tappahannock 11
Ann Arbor 10
Boydton 10
Hong Kong 10
Hyderabad 10
Turin 10
Frankfurt Am Main 9
Baghdad 8
Biancavilla 8
Bronte 8
Kunming 8
New York 8
Princeton 8
Ragusa 8
Siracusa 8
Warsaw 8
Casaleone 7
London 7
Manaus 7
Mumbai 7
Napoli 7
Phoenix 7
Rosolini 7
San Francisco 7
São Bernardo do Campo 7
Totale 11.686
Salva come PNG Salva come JPEG
Nome #
Current drug treatments targeting dopamine D3 receptor 167
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 164
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 163
Dopaminergic-GABAergic interplay and alcohol binge drinking 153
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 150
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 122
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 122
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 115
Design, Synthesis and Antiinflammatory Activity of Novel g-Tocopherol Acetylsalicylic acid Ester Codrug 113
Antioxidant and osmoprotecting activity of taurine in dry eye models 111
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 111
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 108
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 104
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 104
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 99
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 98
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 98
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 96
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 93
Caffeine Protects Against Retinal Inflammation 93
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 92
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 91
Prognostic significance of deregulated microRNAs in uveal melanomas 91
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 90
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 90
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 88
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 87
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 85
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 85
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 82
P2X7 receptor antagonism: implications in diabetic retinopathy 82
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 82
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 81
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 80
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 80
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 79
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 78
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 78
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 77
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 77
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 75
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 75
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 75
Farmacologia Oculare 75
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 75
Acidic mammalian chitinase in dry eye conditions 73
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 73
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 73
L'acido Ialuronico come Carrier Ideale nella Veicolazione Topica Oculare del Timololo 73
Valutazione del tempo di bioerosione di inserti intravitreali a base di esteri dell'acido ialuronico 72
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 72
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 72
Controversies in Glaucoma: Current Medical Treatment and Drug Development 71
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes 71
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 71
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma 70
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 70
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 70
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 70
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 70
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 69
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 68
Rapid determination of nimesulide in rabbit aqueous humor by liquid chromatography 68
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 68
Protective effects of a coumarin derivative in diabetic rats 67
A prolonged release polymeric nanocarrier for ocular administration 67
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 67
Ocular pharmacokinetics profile of different indomethacin topical formulations. 66
Methylprednisolone delivery by Hyalobend corneal shields and its effects on rabbit ocular inflammation 66
Evaluation of tolerability of a series of lipoamino acids using biological membranes and a biomembrane model 66
COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING OCULAR INFLAMMATORY WITH LOWER RISK OF INCREASED INTRAOCULAR PRESSURE 66
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 66
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 66
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 65
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits 65
Novel therapeutics in glaucoma management 65
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats 65
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease 64
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 64
Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation 64
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 64
Protective effects of the sigma agonist Pre-084 in the rat retina 64
Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit 64
Retinal protection and distribution of curcumin in vitro and in vivo 64
Pharmacodynamic and pharmacokinetic profile of a new timolol/pilocarpine formulation 63
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 63
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 63
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 63
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 63
Enhanced ocular anti-inflammatory activity of lbuprofen carried by an Eudragit RS100((R)) nanoparticle suspension 62
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 62
Lipoprotein(a) serum levels in diabetic patients with retinopathy 62
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection 62
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 62
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 62
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 61
Fluoxetine Protects Retinal Ischemic Damage in Mice 61
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients 61
Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: In vivo evidence 61
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 61
Totale 8.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 0 0 0 0 0 0 0 0 0 0 219 90
2020/20211.637 26 144 186 15 435 56 213 11 217 43 193 98
2021/20222.210 248 284 44 36 313 65 326 98 213 38 71 474
2022/20233.735 324 177 55 379 400 611 37 631 878 46 132 65
2023/20241.615 119 235 88 108 83 330 27 120 12 25 283 185
2024/20255.642 82 1.017 337 322 1.365 735 330 281 563 587 23 0
Totale 17.516